JPRN-UMIN000010671Completed未知
Efficacy and tolerability of bixalomer for treatment of hyperphosphatemia in maintenance hemodialysis patients with poor tolerance to sevelamer: a switching study. - Bixalomer for treatment of hyperphosphatemia in patients with poor tolerance to sevelamer: a switching study (BIXA-SWITCH Study)
Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic0 sites50 target enrollmentStarted: May 9, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Patients with an intestinal blockage 2)Patients suffering from severe astriction or diarrhea continuously 3)Patients who have experienced gastrointestinal tract ulcer or a surgery in the abdomen 4)Patients with liver dysfunction (whose AST or ALT value is more than twice, or T-Bil value is more than 1.5 times higher than the standard level of the hospital they visit), or patients with a severe hepatic disorder such as cirrhosis 5)Patients who are expecting a child, lactating or suspected of pregnancy, or patients who want to be pregnant during their participation in this study 6)Patients considered as ineligible for this study by the investigator for another reason
Investigators
Similar Trials
Completed
Phase 4
To assess the Efficacy and tolerability of Bisoprolol in patients with newly diagnosed Stage I essential hypertension.CTRI/2010/091/000632Merck Serono Merck Ltd2,000
Completed
Not Applicable
Comparision of bixalomer (Kiklin) dose timing as phosphate binder and impact in HD patientsHemodialysis patients with hyperphosphatemiaJPRN-UMIN000009792Juntendo University Hospital30
Completed
Not Applicable
Clinical investigation of the safety of ALIMAXX-B biliary stent for bile duct obstructioCBD obstructionmalignant CBD obstruction10018008NL-OMON35349Merit Medical Systems13
Recruiting
Phase 4
EFFICACY AND TOLERABILITY OF BISOPROLOL IN COMPARISON TO METOPROLOCTRI/2010/091/000323Investigator (Rajiv KArnik)200
Active, not recruiting
Not Applicable
Efficacy and tolerability of brinzolamide in patients with elevated intraocular pressureintraocular pressure increasedMedDRA version: 14.1Level: PTClassification code 10022806Term: Intraocular pressure increasedSystem Organ Class: 10022891 - InvestigationsEUCTR2013-001793-21-GRPHARMATHEN S.A.168